Functional assessment of rat complement pathway activities and quantification of soluble C5b-9 in an experimental model of renal ischemia/reperfusion injury

Journal of Immunological Methods

Volumn 412, Issue , 2014, Pages 14-23

  Kotimaa, J ^a,b   van der Pol, P ^a   Leijtens, S ^b   Klar Mohammad, N ^a   Schilders, G ^b   Daha, M R ^a   Rutjes, H ^b   Van Kooten, C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hycult Biotech   (Netherlands)

Author keywords

Complement pathway activity; Functional complement activity ELISA; MBL; Renal ischemia reperfusion injury; SC5b 9

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT MEMBRANE ATTACK COMPLEX; LECTIN; MANNAN BINDING LECTIN; MONOCLONAL ANTIBODY; BLOCKING ANTIBODY; MANNOSE BINDING LECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFACT REDUCTION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT BLOOD LEVEL; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RAT; FEMALE; FUNCTIONAL ASSESSMENT; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; MEASUREMENT ERROR; NONHUMAN; RAT; REPERFUSION INJURY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; HUMAN; IMMUNOLOGY; KIDNEY; LEWIS RAT; METABOLISM; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; VASCULARIZATION; WISTAR RAT;

ANIMALS; ANTIBODIES, BLOCKING; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KIDNEY; MALE; MANNOSE-BINDING LECTIN; OBSERVER VARIATION; RATS; RATS, INBRED LEW; RATS, WISTAR; REPERFUSION INJURY;

EID: 84908266498     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.06.011     Document Type: Article

References (27)

1. Arumugam T.V., Shiels I.A., Woodruff T.M., Granger D.N., Taylor S.M. Ischemia-reperfusion injury. Shock 2004, 21:401. 10.1097/01.shk.0000121227.73012.86.
2. De Vries B., Walter S.J., Peutz-Kootstra C.J., Wolfs T.G.A.M., van Heurn L.W.E., Buurman W.A. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am. J. Pathol. 2004, 165:1677. 10.1016/S0002-9440(10)63424-4.
3. De Vries D.K., Lindeman J.H.N., Tsikas D., de Heer E., Roos A., de Fijter J.W., Baranski A.G., van Pelt J., Schaapherder A.F.M. Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am. J. Transplant. 2009, 9:1574. 10.1111/j.1600-6143.2009.02675.x.
4. De Vries D.K., Van Der Pol P., Van Anken G.E., Van Gijlswijk D.J., Damman J., Lindeman J.H., Reinders M.E.J., Schaapherder A.F., Kooten C.Van Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation. Transplantation 2013, 95:816. 10.1097/TP.0b013e31827e31c9.
5. Diebolder C.A., Beurskens F.J., de Jong R.N., Koning R.I., Strumane K., Lindorfer M.A., Voorhorst M., Ugurlar D., Rosati S., Heck A.J.R., van de Winkel J.G.J., Wilson I.A., Koster A.J., Taylor R.P., Saphire E.O., Burton D.R., Schuurman J., Gros P., Parren P.W.H.I. Complement is activated by IgG hexamers assembled at the cell surface. Science 2014, 343:1260. 10.1126/science.1248943.
6. Dietzschold B., Schwaeble W., Schäfer M.K., Hooper D.C., Zehng Y.M., Petry F., Sheng H., Fink T., Loos M., Koprowski H., Weihe E. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis. J. Neurol. Sci. 1995, 130:11. 10.1016/0022-510X(94)00269-T.
7. Goldsmith S.K., Wals P., Rozovsky I., Morgan T.E., Finch C.E. Kainic acid and decorticating lesions stimulate the synthesis of C1q protein in adult rat brain. J. Neurochem. 2002, 68:2046. 10.1046/j.1471-4159.1997.68052046.x.
8. Gou S.-J., Yuan J., Chen M., Yu F., Zhao M.-H. Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2013, 83:129. 10.1038/ki.2012.313.
9. Hugo F., Krämer S., Bhakdi S. Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement. J. Immunol. Methods 1987, 99:243. 10.1016/0022-1759(87)90134-7.
10. Kirschfink M., Mollnes T.E. Modern complement analysis. Clin. Diagn. Lab. Immunol. 2003, 10:982. 10.1128/CDLI.10.6.982-989.2003.
11. Mollnes T.E., Lea T., Frøland S.S., Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand. J. Immunol. 1985, 22:197. 10.1111/j.1365-3083.1985.tb01871.x.
12. Mollnes T.E., Jokiranta T.S., Truedsson L., Nilsson B., Rodriguez de Cordoba S., Kirschfink M. Complement analysis in the 21st century. Mol. Immunol. 2007, 44:3838. 10.1016/j.molimm.2007.06.150.
13. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009, 361:1676. 10.1056/NEJMra0902814.
14. Noris M., Mescia F., Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat. Rev. Nephrol. 2012, 8:622. 10.1038/nrneph.2012.195.
15. Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: therapeutic interventions. J. Immunol. 2013, 190:3839. 10.4049/jimmunol.1203200.
16. Roos A., Bouwman L.H., Munoz J., Zuiverloon T., Faber-Krol M.C., Fallaux-van den Houten F.C., Klar-Mohamad N., Hack C.E., Tilanus M.G., Daha M.R. Functional characterization of the lectin pathway of complement in human serum. Mol. Immunol. 2003, 39:655. 10.1016/S0161-5890(02)00254-7.
17. Schulze M., Baker P.J., Perkinson D.T., Johnson R.J., Ochi R.F., Stahl R.A., Couser W.G. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int. 1989, 35:60. 10.1038/ki.1989.8.
18. Seelen M.A., Roos A., Wieslander J., Mollnes T.E., Sjöholm A.G., Wurzner R., Loos M., Tedesco F., Sim R.B., Garred P., Alexopoulos E., Turner M.W., Daha M.R. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 2005, 296:187. 10.1016/j.jim.2004.11.016.
19. Sjöholm A.G., Jönsson G., Braconier J.H., Sturfelt G., Truedsson L. Complement deficiency and disease: an update. Mol. Immunol. 2006, 43:78. 10.1016/j.molimm.2005.06.025.
20. Thurman J.M., Marians R., Emlen W., Wood S., Smith C., Akana H., Holers V.M., Lesser M., Kline M., Hoffman C., Christen E., Trachtman H. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin. J. Am. Soc. Nephrol. 2009, 4:1920. 10.2215/CJN.02730409.
21. Trachtman H., Austin C., Lewinski M., Stahl R.A. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat. Rev. Nephrol. 2012, 8:658. 10.1038/nrneph.2012.196.
22. Vallhonrat H., Williams W.W., Dec G.W., Keck S., Schoenfeld D., Cosimi A.B., Pascual M. Complement activation products in plasma after heart transplantation in humans. Transplantation 2001, 71:1308. 10.1097/00007890-200105150-00022.
23. Van der Pol P., Schlagwein N., van Gijlswijk D.J., Berger S.P., Roos A., Bajema I.M., de Boer H.C., de Fijter J.W., Stahl G.L., Daha M.R., van Kooten C. Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation. Am. J. Transplant. 2012, 12:877. 10.1111/j.1600-6143.2011.03887.x.
24. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058. 10.1056/NEJM200104053441406.
25. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140. 10.1056/NEJM200104123441506.
26. Zhou A.Q., Herriott M.J., Leu R.W. Kinetics of the biosynthesis of complement subcomponent C1q by murine macrophages: effects of stimulation by interferon-gamma. J. Interferon Res. 1991, 11:111. 10.1089/jir.1991.11.111.
27. Zhou W., Farrar C.A., Abe K., Pratt J.R., Marsh J.E., Wang Y., Stahl G.L., Sacks S.H. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 2000, 105:1363. 10.1172/JCI8621.